Directorate Change
08/12/2023 09:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231208:nRSH1644Wa&default-theme=true
RNS Number : 1644W Mattioli Woods PLC 08 December 2023
8 December 2023
Mattioli Woods plc
("Mattioli Woods", "the Company" or "the Group")
Appointment of Independent Non-Executive Director
Mattioli Woods plc (AIM: MTW.L), the specialist wealth management and asset
management business, is pleased to announce the appointment of a new
independent Non-Executive Director, Alison McKinna with effect from Monday 11
December 2023.
Alison is an experienced business leader and has a track record of delivering
growth through digital innovation, and customer-focused business
transformations across diverse sectors. She brings a wealth of experience in
strategy development and leadership from her executive experience including
Irwin Mitchell LLP and Social Work England, as well as Non-Executive Director
roles for Chesterfield Royal Hospital NHS Foundation Trust and Cancer Central
CIC. Prior roles also include experience of risk management at Capital One and
business integration programme management at Centrica.
Cancer Central CIC was recognised at the 2021 Public Sector Digital Technology
Leaders Awards for their digital innovation, and Alison was nominated as a
finalist at the 2021 Director of the Year at the UK Women in IT Awards for her
contribution to diversity and inclusion in the technology and construction
industry. Her passion for defining clear strategies and driving improved
performance makes Alison a strong addition to the Board of Mattioli Woods plc.
After a transition period to effect the handovers, the composition of the
Board committees will be:
· Audit Committee:
Martin Reason (Chair), Anne Gunther, Alison McKinna;
· Risk and Compliance Committee:
Alison McKinna (Chair), Anne Gunther, Martin Reason;
· Nomination Committee:
Anne Gunther (Chair), Martin Reason, Ian Mattioli;
· Remuneration Committee:
Martin Reason (Chair), Anne Gunther, and Alison McKinna.
Anne Gunther, Non-Executive Chairman said:
"I am delighted to welcome Alison to our Board. Alison's appointment is part
of our succession planning and brings new skills to the Board. Her track
record and experience of delivering successful, customer focused business
transformations and expertise in digital innovation across several sectors,
aligns with the Mattioli Woods' culture of putting our clients first as we
continue to deliver our ambitious growth strategy for the business".
Additional Information
The following information is disclosed under Schedule 2(g) of the AIM Rules
for Companies:
Alison Heather McKinna (neé Wright) age 56, is currently or has been a
director of the following companies within the past five years:
Current Directorships: Previous directorships:
Shepherds Friendly Cancer Central CIC
BHSF Group Limited Chesterfield Royal Hospital NHS Foundation Trust
BHSF Limited Irwin Mitchell LLP
BHSF Occupational Health Limited Collaborative Procurement Partnerships LLP
BHSF Management Services Limited Social Work England
Auriga Services Limited
Acivico Group Limited
Acivico (Building Consultancy) Limited
Acivico (Design Construction and Facilities Management) Limited
Acivico Traded Services Limited
Acivico Limited
A McKinna Services Limited
Westbourne School Trust Limited
- Ends -
For further information please contact:
Mattioli Woods plc
Ian Mattioli MBE, Chief Executive Officer
Ravi Tara, Chief Financial Officer Tel: +44 (0) 116 240 8700
Michael Wright, Deputy Chief Executive Officer
ww
w.
ma
tt
io
li
wo
od
s.
co
m
Canaccord Genuity Limited (Nominated Adviser and Joint Broker)
Emma Gabriel Tel: +44 (0) 20 7523 8000
Harry Pardoe www.canaccordgenuity.com
Singer Capital Markets (Joint Broker)
Tom Salvesen Tel: +44 (0) 20 7496 3000
Alaina Wong www.singercm.com (http://www.singercm.com)
Media enquiries:
Camarco
Julie Tilley Tel: +44 (0) 20 3757 4984
www.camarco.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAGRBDDGXGDGXI